A detailed history of Rs Crum Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Rs Crum Inc. holds 407 shares of LLY stock, worth $303,703. This represents 0.09% of its overall portfolio holdings.

Number of Shares
407
Previous 314 29.62%
Holding current value
$303,703
Previous $284,000 26.76%
% of portfolio
0.09%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $71,809 - $89,281
93 Added 29.62%
407 $360,000
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $227,609 - $285,438
314 New
314 $284,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rs Crum Inc. Portfolio

Follow Rs Crum Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rs Crum Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rs Crum Inc. with notifications on news.